AKT1 antibody; PKB antibody; RAC antibody; RAC-alpha serine/threonine-protein kinase antibody; Protein kinase B antibody; PKB antibody; Protein kinase B alpha antibody; PKB alpha antibody; Proto-oncogene c-Akt antibody; RAC-PK-alpha antibody; AKT3 antibody; PKBG antibody; RAC-gamma serine/threonine-protein kinase antibody; Protein kinase Akt-3 antibody; Protein ki antibody;
Product description
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene.
Immunogen
The antiserum was produced against synthesized peptide derived from human AKT1. AA range:406-455
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIHC
WB:1:500-1:2000 IHC:1:100-1:300
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Target Information
Alternative Names
AKT1 antibody PKB antibody RAC antibody RAC-alpha serine/threonine-protein kinase antibody Protein kinase B antibody PKB antibody Protein kinase B alpha antibody PKB alpha antibody Proto-oncogene c-Akt antibody RAC-PK-alpha antibody AKT3 antibody PKBG antibody RAC-gamma serine/threonine-protein kinase antibody Protein kinase Akt-3 antibody Protein ki antibody